The differentiation state of small intestinal organoid models influences prediction of drug-induced toxicity
Drug-induced intestinal toxicity (GIT) is a frequent dose-limiting adverse event that can impact patient compliance and treatment outcomes. In vivo, there are proliferative and differentiated cell types critical to maintaining intestinal homeostasis. Traditional in vitro models using transformed cel...
Saved in:
Main Authors: | Jessica A. Klein, Julia D. Heidmann, Tomomi Kiyota, Aaron Fullerton, Kimberly A. Homan, Julia Y. Co |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1508820/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling
by: Weidong Shao, et al.
Published: (2025-01-01) -
Innovations in intestinal organoid technology featuring an open apical surface
by: Ye Chen, et al.
Published: (2025-06-01) -
Intestinal organoids: The path towards clinical application
by: Hady Yuki Sugihara, et al.
Published: (2025-03-01) -
Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations
by: Alia Hadefi, et al.
Published: (2025-01-01) -
Deriving Human Intestinal Organoids with Functional Tissue-Resident Macrophages All From Pluripotent Stem CellsSummary
by: Kentaro Tominaga, et al.
Published: (2025-01-01)